Board of Directors

The Right Honourable Lord James Arbuthnot of Edrom
Chairman

James is an experienced corporate manager and Director. He has worked extensively within Parliament, as a senior Minister and Chief Whip and as Chairman of the Defence Select Committee.  He is Chairman of the Advisory Board of Thales (UK), and advises other companies nationally and internationally.
 

 

Baroness Professor Susan Greenfield, CBE
CEO and Founder

Baroness Greenfield, Founder and CEO of Neuro-Bio Ltd is a neuroscientist and has published over 200 papers in peer-reviewed journals over the course of her 40 year career, based mainly at Oxford University. She holds 32 honorary degrees from UK and foreign universities, has received numerous honours including the Legion d’Honneur from the French Government, an Honorary Fellowship from the Royal College of Physicians, The American Academy of Achievement Golden Plate Award, and The Australian Medical Research Society Medal. She is also a Fellow of the Royal Society of Edinburgh.

David Fuente
Investor Director

Dave is the former chairman and CEO of Office Depot and former president of Sherwin-Williams Paint Stores. In addition to his role as Chairman Emeritus of SSA & Company, he is a Senior Advisor at Peter J. Solomon Company. He formerly served on the boards of Office Depot, Ryder Transportation, Dicks Sporting Good and others. Dave was appointed on the board by Kairos Ventures as an Investor Director for Neuro-Bio.

Dominique Kleyn
Non-Executive Director

Serial biotech start-up entrepreneur, company founder and non-executive director skilled in company growth, business development and marketing for drugs, diagnostics and devices.



 

Dr Peter Alff
Non-Executive Director

Peter works as part of the Kairos Ventures Team as an Executive in Residence, his role is to provide efficient and effective communication of technical and scientific aspects of Neuro-Bio business to Kairos representatives, including the delivery of milestones. Peter supports the business and technological engagements as directed by Neuro-Bio including assisting in: identifying additional funding for research and development with a focus on sources based in the UK, sourcing appropriate partners and R&D resources based in the US and to provide consulation on the overall strategic direction for product development and market engagement and represent Neuro-Bio at scientific and business conferences in the US.